Optimising bortezomib in newly diagnosed multiple myeloma

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)909-910
Number of pages2
JournalThe Lancet Oncology
Volume11
Issue number10
DOIs
StatePublished - Oct 2010

Fingerprint

Alkylating Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Boronic Acids
Pyrazines
Melphalan
Thalidomide
Angiogenesis Inhibitors
Age Factors
Prednisone
Protease Inhibitors
Multiple Myeloma
Bortezomib

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)

Cite this

Optimising bortezomib in newly diagnosed multiple myeloma. / Rajkumar, S Vincent.

In: The Lancet Oncology, Vol. 11, No. 10, 10.2010, p. 909-910.

Research output: Contribution to journalArticle

@article{ac2187b6b8df4213bb5f73ca87527985,
title = "Optimising bortezomib in newly diagnosed multiple myeloma",
author = "Rajkumar, {S Vincent}",
year = "2010",
month = "10",
doi = "10.1016/S1470-2045(10)70199-6",
language = "English (US)",
volume = "11",
pages = "909--910",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "10",

}

TY - JOUR

T1 - Optimising bortezomib in newly diagnosed multiple myeloma

AU - Rajkumar, S Vincent

PY - 2010/10

Y1 - 2010/10

UR - http://www.scopus.com/inward/record.url?scp=77957371003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957371003&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(10)70199-6

DO - 10.1016/S1470-2045(10)70199-6

M3 - Article

C2 - 20739219

AN - SCOPUS:77957371003

VL - 11

SP - 909

EP - 910

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 10

ER -